Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia

British Journal of Haematology

Volumn 111, Issue 2, 2000, Pages 467-473

  Cappellini, M D ^a   Robbiolo, L ^a   Bottasso, B M ^a   Coppola, R ^a   Fiorelli, G ^a   Mannucci, P M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Hypercoagulability; Splenectomy; Thalassaemia; Thrombosis

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROID CELL; FEMALE; FIBRINOLYSIS; HIGH RISK PATIENT; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SPLENECTOMY; THALASSEMIA; THROMBOCYTE ACTIVATION; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADULT; AGED; ANALYSIS OF VARIANCE; ERYTHROCYTES; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SPLENECTOMY; THALASSEMIA; THROMBIN; THROMBOEMBOLISM; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 0034528576     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2000.02376.x     Document Type: Article

References (28)

1. Laboratory markers of coagulation activation
2. Thromboembolic events in beta thalassemia major: An Italian multicenter study
3. Thalassemia intermedia
4. Genetic interactions in thalassemia intermedia: Analysis of β-mutations, α-genotype, γ-promoters, and β-LCR hypersensitive sites 2 and 4 in Italian patients
5. Hypercoagulability in patients with thalassemia intermedia
6. Metabolic indicators of oxidative stress correlate with haemichrome attachment to membrane, band 3 aggregation and erythrophagocytosis in β-thalassaemia intermedia
7. Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age and clearance by mononuclear cells
8. Abnormal platelet function in β-thalassemia
9. Platelet survival in patients with β-thalassemia
10. In vivo platelet activation in β-thalassemia major reflected by increased platelet-thromboxane urinary metabolites
11. E chronic hypercoagulable state in patients with β-thalassaemia major is already present in childhood
12. Pulmonary thromboembolism in thalassaemia intermedia patients
13. Increased procoagulant activity of the red blood cells from a patient with homozygous sickle cell disease and β-thalassemia
14. Flip-flop: The transmembrane translocation of lipids
15. Enhanced adherence of β-thalassaemic erythrocytes to endothelial cells
16. Membrane phospholipid asymmetry in human thalassemia
17. Thromboembolic complications in beta thalassaemia major
18. Role of hemichrome binding to erythrocytes membrane in the generation of band-3 alterations in β-thalassemia intermedia erythrocytes
19. Detection of the prethrombotic state due to procoagulant imbalance
20. Protein C and antithrombin III in polytransfused thalassaemic patients
21. Phosphatidylserine externalisation is a downstream event of interleukine-1β converting enzyme family protease activation during apoptosis
22. The β-thalassemias
23. Iron chelating therapy and the treatment of thalassemia
24. In vivo platelet activation correlates with red cells anionic phospholipid exposure in patients with β-thalassemia major
25. Pulmonary artery obstruction in thalassaemia
26. Pulmonary microthromboemboli in thalassaemic cases
27. Phosphatidylserine in the outer leaflet of red blood cells from β-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes
28. Survival and causes of death in thalassaemia major